Abstract-ATP-sensitive potassium channels couple cell excitability to energy metabolism, thereby providing life-saving protection of stressed cardiomyocytes. The signaling for ATP-sensitive potassium channel expression is still unknown. We tested involvement of biochemical and biophysical parameters and potential transcription factors Forkhead box (FOX) and hypoxia-inducible factor (HIF-1␣). Right atrial tissues were obtained during surgery from 28 children with heart disease. Expression of K ϩ -inward-rectifier subunits Kir6.1/Kir6.2; sulfonyl urea receptors (SURs) SUR1A/B and SUR2A/B; and FOX class O (FOXO) 1, FOXO3, FOXF2, and HIF-1␣ were related to 31 parameters, including personal data, blood chemistry, and echocardiography. Venous hypoxemia (but not other ischemia indicators, such as venous hypercapnia or low glucose) predicts increased Kir6.1 (PϽ0.003) and Kir6.2 (PϽ0.03) protein. Kir6.1 associates with SUR2A/B mRNA (PϽ0.05) and correlates with FOXOs (PϽ0.002). FOXOs correlate with HIF-1␣ (PϽ0.01) and HIF-1␣ with venous hypoxemia (PϽ0.003). Electrophoretic mobility-shift assays suggest causal links among hypoxia, HIF-1␣, FOXO1, and Kir6.1. To mimic mild ischemia encountered in some patients, cultured rat atrial myocytes were tested in hypoxia, hypercapnia, or low glucose, with normal conditions serving as the control. Mild hypoxia (24-hour) increases expression of HIF-1␣, FOXO1, and SUR2A/B/Kir6.1 in culture (PϽ0.01), whereas hypercapnia and low glucose have no or opposite effects. Gene knockdown of HIF-1␣ or FOXO1 by small-interfering RNAs abolishes hypoxia-induced expression of FOXO1 and SUR2A/B/Kir6.1. These results suggest that low tissue oxygen determines increased expression of the atrial SUR2A/B/Kir6.1 gene via activation of HIF-1␣-FOXO1. Because increased SUR2A/B/Kir6.1 has known survival benefits, this pathway offers novel therapeutic targets for children with heart disease. (Hypertension. 2010;55:1186-1192.) Key Words: cardiovascular diseases Ⅲ low oxygen Ⅲ ion channels Ⅲ ischemia Ⅲ transcription A TP-sensitive potassium channels (KATPs) are important (and beneficial) in pathological situations, such as tissue ischemia and ischemic-reperfusion injury. 1,2 Practically all tissues, including heart, kidney, brain, and blood vessels, contain KATP subtypes, with their specific molecular composition, pharmacology, and channel conductance. 3 KATPs are hetero-octamers of 4-pore subunits (potassium inward rectifiers Kir6.1 or 6.2), and 4 regulatory subunits (sulfonyl urea receptors [SURs] SUR1A, SUR1B, SUR2A, or SUR2B). 4 They couple energy expenditure to energy supply, thereby adjusting contraction to the current metabolic status of the cardiomyocytes. 5 KATPs are vitally important in physiological situations as well. In mice performing vigorous exercise, suppression of Kir6.2 greatly limits the maximal performance. Half of them die, most likely from arrhythmias, because the myocytes no longer reduce the duration of the action potential during a metabolic challenge. 6,7 Interestingly, functional sarcolemmal KATPs are required for long-term, exercise-induced cardioprotection. 8 Whether KATP expression varies in patients with heart disease is little known. Increased expression would help preserve the function of a disease-compromised heart. Acute severe ischemia indeed triggers expression of Kir6.1 in rats. 9 The effect of chronic mild ischemia encountered in many cardiac diseases is unknown, and signaling pathways underlying ischemia-induced changes in KATP remain obscure. Ischemia is usually ill defined, resulting in unknown extracellular changes of pH, PaCO 2 , PaO 2 , substrates, metabolites, and potassium.
with heart disease offer an excellent model, because right atrial fragments can be salvaged for biochemical studies, and a large array of physiological variables can be ascertained. The second goal was to test potential causal relationships and ischemia-related extracellular changes on isolated atrial myocytes in vitro. The third goal was to explore the signaling pathways involved, both ex vivo on human atrial fragments and in vitro. The results suggest a remarkable new transduction mechanism for cardiomyocyte survival in heart disease.
Methods
Full methods are described in the online Data Supplement at http://hyper.ahajournals.org.
Patients
This study reports results from 28 children operated for congenital or acquired heart disease. Informed consent was obtained from the children's parents or guardian. Children were aged 5 months to 16 years and harbored pathologies such as Tetralogy of Fallot and ventricular septal defects. The wide range of patient parameters allowed for a detailed multivariate statistical analysis of KATP expression.
Human Protocol
Personal, echocardiographic, and electrocardiographic parameters were collected during preoperative consultations ( Figure S1 and Table S1 in the online Data Supplement). Artificial respiration was switched during 5 minutes from 50% to 21% oxygen before taking venous and arterial blood samples (0.3 mL) for immediate blood analysis. Right atrial appendage tissue discarded during surgery was collected in liquid nitrogen (for protein and RNA extractions), and PBS for histology and electrophoretic mobility-shift assay (EMSA).
Western Blots
Right atrial appendage tissue (3 mm 3 ) was placed in homogenization/lysis buffer and processed. 10 Reference samples were coapplied for intergel comparisons. Specific antibodies ( Figure S2 ) included anti-Kir6.1 (R14, SC-11224), anti-Kir6.2 (G16, SC-11228), and anti-Forkhead Box (FOX) transcription factor F2 (anti-FOXF2; ab23306, Abcam).
mRNA Measurements
After RNA extraction and reverse transcription, real-time PCR was performed 10 with specific primers for human KATP subunits, transcription factors FOX class O (FOXO) 1, FOXO3, FOXF2, hypoxiainducible factor (HIF-1␣), cytokine tumor necrosis factor-␣, and insulin-like growth-factor 1 mRNA (Table S2 ). Data were normalized by hypoxanthine phosphoribosyltransferase. 11 
Immunohistology
Sections were stained with anti-atrial natriuretic peptide antibody for confocal microscopy or hematoxylin-eosin to determine the distribution of myocytes, blood vessels, and connective tissue ( Figure S3 ).
Electrophoretic Mobility-Shift Assay
Nuclear protein was extracted from fresh human right atrial tissue (3 patients) or rat atrial myocytes cultures. EMSAs were run 10 with probes containing an HIF-1␣ or FOXO1 consensus site.
In Vitro Experiments
Cause-and-effect relationships and potential signaling pathways were tested with atrial myocytes from neonate rats. 10 Small interfering RNAs (siRNAs) were applied over 24 hours to knock down FOXOs or HIF-1␣ mRNA. siRNAs with scrambled sequence served as control. Culture conditions tested ischemia parameters, such as low glucose (1.25 or 2.50 mmol/L), high potassium (10.00 mmol/L), mild hypoxia (2% O 2 ), or mild hypercapnia (8% CO 2 ; decrease of 0.3 pH units). Reverse-transcription/real-time PCR (see above) was performed on rat KATP subunits, FOXOs, and HIF-1␣ mRNA (Table S2) . Rat hypoxanthine phosphoribosyltransferase mRNA was measured for normalization. Western blot involved antibodies against Kir6.1 (R14 SC-11224), Kir6.2 (Alomone), FOXO1 (Abcam), FOXO3 (Abcam), HIF-1␣ (Novus Biological), ␤-actin (Sigma), and SUR1/2 (D18 SC-5791).
Statistical Analysis
Means were compared by unpaired ANOVA with a Tukey method for post hoc comparisons. Pearson correlations on Յ25 patients (Tables S3 and S4) were performed with SPSS. S-PLUS software calculated optimized stepwise multivariate regressions with subgroups from 31 input parameters. Drug treatments and sex had no significant associations with Kir6 or FOXOs.
Results

Characterization of Human Right Atrial Tissue and Kir6 Antibodies
Tissues display the characteristic wall layers of cardiac chambers ( Figure S1B1 ). Myocytes show prominent staining for atrial natriuretic peptide ( Figure S1B2 and S1B3). Quantitative analysis ( Figure S3 ) from 3 patients indicates that 43% of the tissue sample consists of cardiomyocytes, 49% of connective tissue, and Ͻ3% of histologically identifiable blood vessels. Because fibroblasts have little KATP, most channel proteins originate from the myocytes. Antibodies were specific and suitable for quantification of Kir6 proteins, and species-specific elution patterns were consistent with previous studies ( Figure S2 ). 10, 12 
Venous Hypoxemia Predicts Human Kir6 Overexpression
Expression of KATP subunits (Յ25 patients) was related to blood gases, pH, and chemistry, echocardiographic, and personal parameters (Table S1 ). Channel protein and mRNA were also grouped according to the median of blood gases, pH, glucose, and potassium (Figures 1 and S4 (Figure 2 ).
Stepwise multiple regressions for all of the patients (including the 8 above) show that Kir6.1 protein highly and negatively correlates with venous PaO 2 and weakly and positively with plasma glucose ( Figure 2D 
Hypoxia Stimulates KATP Expression in Culture
The mRNA expression of KATP subunits ( Figure 3 ) was compared for mild 13 hypoxia (24 hour, 2% O 2 , 5% CO 2 , 5 mmol/L of glucose, 5 mmol/L of K ϩ ) and control (19% O 2 , 5% CO 2 ). Kir6 and SUR2 subunits are significantly overexpressed during mild hypoxia. Hypercapnia (associated with lower pH), high potassium (associated with hypoxia), or low glucose have no or opposite effects. SUR1 subunit expression varies little, whatever the conditions (data not shown). Figure  S5 (and its legend) indicates a significant increase of Kir6.1, Kir6.2, and SUR1/2 proteins with 2% O 2 . These results suggest that tissue hypoxia directly causes overexpression of KATP, with little contribution from low pH, low glucose, or high potassium. (Table 2) , SUR2B, and SUR2A ( Figure S6 ). To check causal links, nuclear protein extracts from patient atrial tissue were run in EMSA (Figure 4) . In gel 1, the probe is shifted upward by nuclear protein extract of venous hypoxic patient A, displaced from the hot probe by a competitor cold probe, and supershifted upward by adding anti-FOXO1 antibody. In gel 2, the intensity of the shifted and supershifted bands of venous hypoxic patient C far exceeds the intensity for venous normoxic patient B. This experiment suggests that FOXO1-like nuclear protein can bind to the Kir6.1 gene promoter in a venous hypoxiadependent manner.
HIF-1␣-Associated Increase of Human FOXO and Kir6.1
HIF-1␣ expression was tested, because hypoxia stabilizes HIF-1␣ protein via inhibition of prolyl hydroxylase domain proteins, 14, 15 and bioinformatics 10 suggests that HIF-1␣ transactivates the FOXO genes. HIF-1␣ mRNA is increasingly expressed at lower venous oxygen saturation (PϽ0.003), does not correlate with arterial oxygen saturation, and tightly couples to FOXOs and Kir6.1 mRNA ( Table 2 ). In EMSA ( Figure S7A ), nuclear protein extracts from patient B and even more so patient C shift the HIF-1␣ probe, suggesting that an HIF-1␣-like protein binds venous hypoxia dependently to the HIF-1␣ consensus of the human FOXO1 
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promoter. Nuclear protein extracts from atrial cultures were run in an EMSA for HIF-1␣ ( Figure S7B ). The shifted band for the hypoxic sample is 1. In cultures nucleoporated with scrambled-sequence siRNA, mild hypoxia causes robust increases of FOXO1, Kir6.1, and SUR2 mRNAs ( Figure 5 ). Figure S8 verifies that HIF-1␣ and FOXO1 proteins significantly increase after 4-, 7-, and/or 24-hour exposure to 2% O 2 . FOXO3 protein does not change during 24-hour hypoxia (data not shown), possibly because FOXO3 responses may be delayed relative to FOXO1. 10 siRNAs against HIF-1␣ or FOXO1 mRNA abolish the hypoxia-induced responses. Moreover, Figure S9 verifies that the nucleoporation of siRNAs against HIF-1␣ or FOXO efficiently knock down the corresponding mRNAs, as well as downstream targets in the signaling cascade.
Lack of Evidence for 2 Other Signaling Pathways
Does hypoxia activate insulin-like growth factor 1, AKT1 (also known as protein kinase B), and HIF-1␣? 16 This seems unlikely here, because insulin-like growth factor 1 mRNA does not correlate with venous PaO 2 , Kir6.1, or Kir6.2 mRNA ( Figure S10A1 ). In addition, the AKT1 inhibitor Wortmannin has no effect in vitro ( Figure S10B1 ). Alternatively, hypoxia might stimulate the angiotensin 2 receptor and tumor necrosis factor-␣-induced activation of jun-N-terminal kinase, nuclear targeting of FOXO, and activation of Kir6. 17 However, human right atrial jun-N-terminal kinase mRNA does not correlate with venous PaO 2 , Kir6.1, or Kir6.2 mRNA ( Figure  S10A2 ). Furthermore, inhibition of jun-N-terminal kinase does not significantly affect the hypoxia-induced increase of Kir6.1 in culture ( Figure S10B2 ).
Discussion
This study identifies, for the first time, a combination of biochemical, biophysical, and transcription factors in stressinduced expression of the life-saving KATP.
Upregulation of Human KATP in Venous Hypoxemia
Of 31 parameters measured, venous hypoxemia best predicts increased expression of human right atrial Kir6.1 and Kir6.2. Venous hypoxemia may result from low cardiac output in some children suffering from heart disease. 18, 19 Neither low arterial PaO 2 nor low hemoglobin could have been the main cause for low venous PaO 2 , or the increased Kir6 expression. Right ventricular hypertension 20 results in increased right atrial pressure and right ventricular thickness. The latter does not correlate with Kir6.1 protein when pathologies are included in the regression analysis, thereby weakening the case for a mechanically stimulated right atrial KATP expression. The small but significant effect of plasma glucose needs further study.
The in vitro studies prove the concept that low tissue PaO 2 is an important determinant for KATP overexpression. Both human and in vitro studies exclude other ischemia-associated parameters measured in this study. [21] [22] [23] [24] suggest 2 potential benefits of this plasticity: increased sensitivity to metabolic stress 22 and prevention of excessive shortening of the action potential and, thus, reduction of the risks of re-entry arrhythmia. 9, 22, 25 Interestingly, SUR1 overexpression, which might have increased the risks of arrhythmias, 26, 27 did not occur in patients or in vitro. This remarkable survival strategy of cardiomyocytes points to the HIF-1␣-FOXO1-Kir6.1 signaling pathway as a novel therapeutic target in pediatric cardiac disease. Moreover, this pathway should not unwittingly be suppressed when treating other pathologies. Figure 5. Response of KATP mRNAs to mild hypoxia in culture: siRNAs directed against HIF-1␣ or FOXO1 abolish response. Dissociated rat atrial cardiomyocytes were nucleoporated with siRNA (note efficacy in Figure S9 ) and cultured for 24 hours in normoxia (19% O 2 ) or mild hypoxia (2% O 2 ; 6 to 9 wells per group per condition). mRNA levels (meanϮSEM) for hypoxia were expressed in percentage of mean for normoxia. for Electrophoretic Mobility-Shift Assays (EMSA). The variety in pathologies were an advantage in this study, since the resulting wide range in patient parameters allowed for a more precise prediction of KATP gene expression. Tissues from 30 more patients were obtained; some of these were used for optimizing the protocol, others stemmed from re-operated patients or patients for whom the planned data collection could not be followed. The detailed drug protocol during surgery is available upon request.
Sources of Funding
Protocol
Personal, echocardiographic and electrocardiographic parameters (Tables S1, S3 , S4) were collected during preoperative consultations usually within one week of cardiac surgery (Fig. S1) . Personal characteristics included age, size, weight, gender, and current drug treatments. Echocardiographic parameters were sizes of the right atrium (RA), left atrium (LA), right ventricle (RV), left ventricle (LV), area of LA, thickness of RV and LV, shortening fraction, and ejection fraction. The ultrasound probe was carefully placed at a consistent angle throughout the study. Electrocardiographic parameters included the PR, QRS and QTc intervals, heart rate, and presence/absence of sinus rhythm; computer calculated values were verified by measurements on the printed ECGs. After initiation of anaesthesia, catheters were inserted by taking care to consistently place the tip of the venous catheter at the entry of the right atrium. Artificial respiration was switched during 5 minutes from 50% to 21% oxygen. After this equilibration -designed to reach the blood gas levels presumably prevailing before anaesthesia -venous and arterial blood samples (0.3 ml) were withdrawn for immediate analysis of blood gases, pH, and plasma concentrations of glucose, Ca ++ , Na + , K + , Cl -and calculated bicarbonate on a Radiometer ABL800 FLEX. In order to install the cardio-pulmonary bypass, surgery required cutting a small piece of the tip of the right atrial appendage. Part of the tissue was collected in liquid nitrogen (for protein and RNA extractions), and part was washed in PBS and fixed in 3% paraformaldehyde (for histology). separately (32 μg protein) for loading on a polyacrylamide-SDS-gel (10%), and blotted 1, 2 . Loading controls were always performed by red Ponceau staining, and in some cases also by β-actin staining (Sigma A5441, 1:5,000), and quantified by Metamorph software (Universal Imaging, Downingtown, PA). Reference samples were co-applied in all gels to allow for inter-gel comparisons of Kir6 signals. In spite of the small tissue size, 3 types of proteins could be tested. Polyclonal goat antiKir6.1 antibody (R14 Santa Cruz Biotechnology (SC)-11224) and anti-Kir6.2 (G16 SC-11228) were diluted 1:400 and 1:300, respectively. The Kir6.1 antibody was checked with INS-1 cell extracts devoid of Kir6.1 (not shown). Specificities were further checked as shown in Fig. S2 . Rabbit polyclonal anti-FOXF2 antibody (ab23306) was obtained from Abcam (Cambridge), and applied at a dilution of 1:2,000. Polyclonal rabbit anti-Kir6.2 antibody (Alomone, Jerusalem, Israel) was used for rat experiments as described 1 . Quantification of the detected proteins was performed by scanning and with MetaMorph software.
Western Blots
RNA extraction, reverse transcription and real time PCR
After RNA extraction and reverse transcription, real time PCR was performed with specific primers for human KATP channel subunits Kir6.1, Kir6.2, SUR1A, SUR1B, SUR2A, and SUR2B, transcription factors FOXO1, FOXO3, FOXF2, and HIF-1α, cytokine TNFα, and IGF-1 mRNA. The primers were designed by Primer Express® software v2.0 from Applied Biosystems and synthesized by Mycrosynth® (Balgach, Germany) (Table S2), as described 1 . Standard curves were established with a mix of all samples, and values normalized by HPRT (Hypoxanthine Phosphoribosyl Transferase), cyclophilin, 18s and RPL19 (Ribosomal Protein L19). HPRT was chosen as the representative normalization gene, as in previous human studies 3 , because rRNA 18S was poorly correlated with the other reference genes, and because both cyclophilin and RPL19 might be affected by hypoxia 4 .
Immunohistology
Right atrial appendage sections were stained with anti-ANP antibody (dilution 1:1,000), a marker of atrial myocytes (Peninsula Laboratories T-4015) (48 h at 4 °C), and processed and imaged by confocal microscopy 2 . Other sections were stained by haematoxylin-eosin (Dr. Annelise Wohlwend, Geneva) in order to determine the quantitative distribution of myocytes, blood vessels and connective tissue. Details of surface measurements are given in Fig. S3 .
Electrophoretic Mobility-Shift Assays (EMSA)
We checked whether human nuclear FOXO1 protein binds to a P 32 -labeled DNA probe whose sequence corresponds to the FOXO1 consensus site within the promoter of the human or rat Kir6.1 gene. Similarly, EMSAs were run with a DNA probe whose sequence corresponds to the HIF-1α consensus site within the promoter of the human or rat FOXO1 gene. Nuclear protein was extracted from fresh human right atrial tissue or from rat atrial myocytes cultures, and EMSA run as described previously 1 and in the legend to Fig. 4 and S7. Nuclear extractions from frozen-thawed tissue did not work. Both normoxic and hypoxic tissues or cells were tested in these assays.
In vitro experiments
The aim was to test cause-and-effect for the relationships discovered in the human study, and to check whether O 2 partial pressure, CO 2 partial pressure, pH, glucose, Supplement Hypertension -Raeis et al - Page 4 or potassium were involved in expression of KATP. Rat cells were studied, because cell yield from the small human atrial tissue fragment is inadequate for siRNA experiments. In addition, although FOXO1 K.O. mice would be an interesting model, such mice die before birth, and conditional atrium-specific FOXO1 K.O. mice are not yet available 5 .
Hearts from 2-to 3-day-old male and female Sprague-Dawley rats were carefully microdissected to collect atrial appendages, the cells dissociated and preplated on plastic to remove fibroblasts, nucleoporated (up to 2 million cells/well) with number 09 protocol of Amaxa AG (Köln, Germany) to introduce small interfering RNAs (siRNAs), and cultured as described previously 1 . siRNAs were obtained from Invitrogen to knock down FOXO1, FOXO3, or HIF-1α mRNA. siRNAs with scrambled sequence served as control (Fig. 5 and S9) . The siRNA experiments were run over 24 hours, since at that time fluorescent siRNA could be detected inside the myocytes, while no fluorescence was visible after 48h. Furthermore, preliminary experiments had shown that mRNA knock-down was maximal at 24h and vanished at 48h.
For each culture, one half of the culture wells was incubated for 24 h at 2 % O 2 -5% CO 2 and the other half at 19 % O 2 -5 % CO 2 . This represents a very mild hypoxia, since most other studies applied 1% or even 0.1% O 2 6, 7 , and the threshold for hypoxia in culture is around 3% O 2 6 . The usual medium was DMEM-F12 with 10 % FBS, insulin-selenium-transferrin, penicillin-streptomycin, and ascorbic acid. Other media tested were DMEM (without glucose; D5030, SIGMA) with 10% FBS, supplemented with 1.25, 2.5 or 5 mmol/L glucose, or supplemented with 5 mmol/L glucose and 10 mmol/L KCl. Effects of low pH were tested by setting the incubator CO 2 concentration at 8%. To prevent fibroblast proliferation, 20 µmol/L 1-β-Darabinofuranosylcytosine was added to the culture medium. At the end of the test (usually 24h), RNA was extracted and subjected to reverse transcription/real time PCR (see above) for estimating rat Kir6.1, Kir6.2, SUR1A, SUR1B, SUR2A, SUR2B, FOXO1, FOXO3, and HIF-1α mRNA (Table S2 ). Rat HPRT mRNA was measured for normalization purposes. The pellet of protein extracts from atrial cell cultures were blotted and studied with antibodies against Kir6.1 (R14 SC-11224; at 1:400), Kir6.2 (Alomone, Jerusalem, Israel; at 1:400), FOXO1 (Abcam, ab12161; at 1:4,000), FOXO3 (Abcam, ab17026; at 1:3,000), and HIF-1α (Novus Biological, NB100-479; at 1:1,000). CoCl 2 -stimulated COS cells (NB 800-PC26, Novus) served as positive controls for HIF-1α expression.
Statistical analysis
For patients, data are presented as mean±S.E.M., with N representing the number of patients. When all parameters could not be measured on all patients, N was < 25 as indicated. Mean values obtained were compared by the unpaired ANOVA test with a Tukey method for post-hoc comparisons. Ranked data were used when values were not normally distributed. Pearson correlations were performed with SPSS software. S-PLUS software was used to calculate optimized stepwise multivariate regressions with subgroups of 31 input parameters, and to construct 3D-graphs (example Fig.  2D ). Effects of pathology were analyzed as a co-factor within the regression analysis, as indicated in text. Drug treatments (not shown) or gender had no significant associations with Kir6, FOXO, or PR interval. Rat myocyte experiments were analyzed as described previously 1 and as indicated in legends to Fig. 3 and 5 , and Fig. S5, S7 , S8, S9 and S10.
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Supplement Results
Effects of age, pathology, and cyanotic disease The children's right atrial Kir6.1 and Kir6.2 proteins significantly increase with age (p<0.008), as in mice 8 , and age-related height and weight. Regressions were recalculated by correcting for age. The inverse correlation between right atrial Kir6.1 protein and venous PaO 2 is preserved (p=0.027), as is the inverse correlation between Kir6.2 and venous percent oxygen saturation (p=0.032). The inverse correlations remain significant even when excluding a patient with the lowest venous PaO 2 from the analysis, or when considering only the children that are ≤ 58 months old. Pathology does not significantly associate with Kir6.1 protein, and when entered as co-factor in the analysis, the significance of the inverse relationship between Kir6.1 expression and venous PaO 2 is preserved (p<0.02). Cyanotic and non-cyanotic subgroups both show the same inverse relationship between venous PaO 2 and Kir6.1 expression (p≈ 0.05). Entering pathology as a co-factor also preserves the relationship between Kir6.1 protein and plasma glucose (p<0.05), but other relationships disappear.
Increased Kir6.1 associates with increased SUR2B in human right atrium Does increased SUR expression match increased Kir6? SUR1A and SUR1B expression is stable over the patient population, and does not co-vary with any of the Kir6 subunits (not shown). However, expression of Kir6.1 is significantly correlated with SUR2A and especially SUR2B (p<0.015, N=24, R=0.499). Kir6.2 mRNA displays pronounced but non significant trends. Although specific SUR2 proteins could not be measured because of the small tissue size and lack of specific antibodies, covariance of Kir6.1 with SUR2 mRNA suggests increased KATP. Western blots of human right atrial protein extracts with anti-Kir6 antibodies from Santa Cruz Biotechnology that were used for quantifying the human Kir6. A, Peptide P1 used for generating the anti-Kir6.1 antibody (R14) extinguishes the 48 kDa band of Kir6.1. B, Peptide P2 used to generate the anti-Kir6.2 antibody (G-16) strongly diminishes a band close to 50 kDa. The weak non-specific band at 70 kDa is little affected by P2. C, Western blots for extracts from two different human right atria (H1, H2) and two different rat atrial myocyte cultures (R1, R2) using two anti-Kir6.2 antibodies. Note different elution patterns for human and rat, with a major band around 50 kDa for human, and a major band (or double-band) around 37 kDa for rat Kir6. Figure S5 . Effect of mild hypoxia on Kir6 proteins in culture A, Increased expression of Kir6.1 and Kir6.2 staining after mild hypoxia (2% O 2 , 24h) in rat atrial myocytes. All cultures were immuno-stained at the same time at the same conditions. All settings were the same during acquisition (Laser intensity, camera exposure time) and display. N = 23 to 49 myocytes / group / condition. Calibration bar = 10 μm. B, Increased expression of Kir6.1 and Kir6.2 protein after mild hypoxia as measured in Western blots. Bands were quantified, normalized by β-actin, and expressed in % of normoxic controls. N = 9 wells / group / condition. Statistical significance (relative to normoxia): * p<0.05; *** p<0.005; **** p<0.001. SUR1/2 (not shown) increases to 119.4 +-4.5 % (N=11-13, p<0.01) . Figure S9 . siRNAs efficiently knock down targeted mRNAs and downstream effectors mRNAs extracted from normoxic cultures subjected to specific siRNAs are expressed here relative to mRNA level using scrambled sequence siRNA (SCR=100%). Means ± SEM are from 6 to 9 wells each (*p<0.05; **p<0.01;***p<0.005; ****p<0.001 relative to SCR). Note strong inhibition of Kir6.1 mRNA by siRNA directed against HIF-1α and FOXOs. 
Preoperative consultations
